Futamura Aya, Nozawa Dai, Araki Yuko, Tamura Yunoshin, Tokura Seiken, Kawamoto Hiroshi, Tokumaru Yuichi, Kakihara Sora, Aoki Takeshi, Ohtake Norikazu
Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan.
Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan.
Bioorg Med Chem. 2017 Oct 15;25(20):5203-5215. doi: 10.1016/j.bmc.2017.07.051. Epub 2017 Jul 29.
The design, synthesis, and structure activity relationships of the novel class of pyrazolylethylbenzamide orexin receptor 1-selective antagonists are described. Further derivatization of the prototype dual orexin receptor 1/2 antagonist lead (1) by installing a (S)-methyl group into the ethyl linker moiety between the pyrazole ring and benzamide resulted in an increase of the antagonist potency against orexin receptor 1/2 receptors. Optimization of the benzamide and pyrazole parts of compounds 2 and 9b led to the identification of N-ethyl-5-fluoro-N-{(2S)-1-[5-(4-fluorophenyl)-2H-tetrazol-2-yl]propan-2-yl}-2-(pyrimidin-2-yl)benzamide (24), which exhibited excellent antagonistic activity against orexin receptor 1 with an IC of 2.01nM and a 265-fold selectivity for orexin receptor 1 over orexin receptor 2.
本文描述了新型吡唑基乙基苯甲酰胺类食欲素受体1选择性拮抗剂的设计、合成及其构效关系。通过在吡唑环和苯甲酰胺之间的乙基连接部分引入一个(S)-甲基,对原型双食欲素受体1/2拮抗剂先导物(1)进行进一步衍生化,导致其对食欲素受体1/2的拮抗活性增强。对化合物2和9b的苯甲酰胺和吡唑部分进行优化,得到了N-乙基-5-氟-N-{ (2S)-1-[5-(4-氟苯基)-2H-四唑-2-基]丙烷-2-基}-2-(嘧啶-2-基)苯甲酰胺(24),它对食欲素受体1表现出优异的拮抗活性,IC为2.01 nM,对食欲素受体1的选择性是食欲素受体2的265倍。